Yoshiko Irie

发表

The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial

T. Ohyama, S. Kitano, H. Iwata, 2019, Breast cancer research and treatment.

Association of a home-based nursing service during chemotherapy with the transfer to home care immediately after the last chemotherapy treatment in patients with advanced cancer

Takahiro Higashibata, J. Hamano, Yoshiko Irie, 2022, Japanese journal of clinical oncology.